Trials / Completed
CompletedNCT04472377
HPV Typing Between Self- and Physician-sampled
Evaluate the Agreement of High-risk Human Papillomavirus Type Between Self-collected Vaginal Discharge Sample Using "HygeiaTouch Self Sampling Kit for Woman" and Physician Collected Sample From the Cervix
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,210 (actual)
- Sponsor
- Hygeia Touch Inc. · Industry
- Sex
- Female
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Hygeia Touch Inc. developed a safe and comfortable vaginal self-sampling device "Hygeia Touch Self Sampling Kit for Women" to self-collect the vaginal discharge sample for high-risk Human Papillomavirus (hrHPV) detection. This clinical trial aimed to evaluate the agreement of hrHPV detections between vaginal self-sampling using "Hygeia Touch Self Sampling Kit for Women" and physician sampling, and these results will be applied for TFDA registration approval.
Detailed description
Primary end-point: 1. Agreement of hr-HPV types, including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, between the physician-collected sample and self-collected sample 2. Agreement of the presence of hr-HPV between the physician-collected sample and self-collected sample Secondary end-point: 1. Percentage of the valid sample between self-collected and physician-collected specimens 2. Agreement of all (N = 27) HPV types between the paired samples 3. Adverse events associated with sample collection 4. Questionnaire of the appreciation and satisfaction of using self-collecting vaginal discharge sample using "Hygeia Touch Self Sampling Kit for Women" through a short movie and a brief illustration 5. Correlation between histological diagnosis and HPV types
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Self sampling kit for collecting discharge from vaginal fornix | A device to collect exfoliative cells from vaginal fornix that can self-operated with ease and comfort. |
Timeline
- Start date
- 2020-05-29
- Primary completion
- 2021-12-21
- Completion
- 2022-04-18
- First posted
- 2020-07-15
- Last updated
- 2024-10-03
- Results posted
- 2024-08-12
Locations
3 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04472377. Inclusion in this directory is not an endorsement.